Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing risankizumab to vedolizumab in adults with moderate-to-severe ulcerative colitis is currently recruiting to assess changes in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab) (vedolizumab)
• Skyrizi (risankizumab) (risankizumab)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis | Phase 3 | Status: RECRUITING